期刊文献+

子宫内膜浆液性癌的发生、发展模式 被引量:3

原文传递
导出
摘要 在过去20多年里,学者们从流行病学、临床病理和分子遗传学等方面对子宫内膜癌进行了大量的研究,关于其发病机制,
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2011年第6期472-475,共4页 Chinese Journal of Obstetrics and Gynecology
  • 相关文献

参考文献27

  • 1Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gyneeol Oneol, 1983, 15:10-17.
  • 2Sagr ER, Denschlag D, Kerim-Dikeni A, et al. Prognostic factors and treatment-related outcome in patients with uterine papillary serous carcinoma. Anticancer Res, 2007, 27 : 1213-1217.
  • 3Wheeler DT, Bell KA, Kurman RJ, et al. Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. Am J Surg Pathol, 2000, 24:797-$06.
  • 4Atnbros RA, Sherman ME, Zahn CM, et al. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol, 1995, 26: 1260-1267.
  • 5Zheng W, Khurana R, Farahmand S, et al. p53 itmnunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary sm'ous carcinoma. Am J SHrg Pathol, 1998, 22:1463-1473.
  • 6Zheng W, Schwartz PE. Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management. Gynecol Oncol, 2005, 96 :579-582.
  • 7Zhcng W, Liang SX, Yu H, et al. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I : morphologic ieatures, lnt J Surg Pathol, 2004, 12:207-223.
  • 8Zheng W, Cao P, Zheng M, et al. p53 overexprcssion and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes. Gynecol Oncol, 1996, 61: 167-174.
  • 9Liang SX, Chambers SK, Cheng L, et al. Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part lI :molecular features. Int J Snrg Pathol, 2004, 12:319-331.
  • 10Jia L, Liu Y, Yi X, et al. Endometrial ghmdular dysplasia with frequent p53 gene mutation: a genetic evidenee supporting its preeancer nature for eudometrial serous carcinoma. Clin CancerRes, 2008, 14:2263-2269.

同被引文献27

  • 1王慧君,郑文新.Ⅱ型子宫内膜癌的前驱病变及其发生模式[J].中华病理学杂志,2007,36(8):505-507. 被引量:5
  • 2del Carmen MG, Birrer M, Schorge JO. Uterine papillary serous cancer: A review of the literature [J]. Gynecol Oncol, 2012,127 (3) :651-661.
  • 3Eavie O, Ben-Arie A, Gemer O. Possible association between BRCA-1 carriers and incidence of uterine papillary serous carcinoma (UPSC) [J]. lnt J Gynecol Cancer, 2008,18 (5) : 1150-1150.
  • 4Morgan J, Hoekstra AV, Chapman-Davis E, et al. Synuclein-ga (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma [ J ]. Gynecol Oncol, 2009,114 (2) : 293-298.
  • 5Zheng W, Liang SX, Yu H, et al. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features [J]. lnt J Surg Pathol, 2004, 12 (3) : 207-223.
  • 6Yi X, Zheng W. Endometrial glandular dysplasia and endometrial intraepithelial neoplasia [J]. Curt Opin Obstet Gynecol, 2008, 20( 1 ) : 20-25.
  • 7Signorelli M, Guerra L, Buda A, et al. Role of the integrated PDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases [J]. Gynecol Oncol, 2009,115 (2) :231 - 235.
  • 8Moore KN, Fader AN. Uterine Papillary Serous Carcinoma [J]. Clin Obstet Gynecol, 2011,54(2) :278-291.
  • 9Ikeda Y, Oda K, Hiraike-Wada O, et al. Cyclin D1 harboring the T286I mutation promotes oncogenic activation in endometrial cancer [J]. Oncol Rep, 2013,30(2):584-588.
  • 10Kontos CK, Scorilas A. Kallikrein-related peptidases (KLKs) : a gene family of novel cancer biomarkers [J]. Clin Chem Lab Med, 2012,50( 11 ) : 1877-1891.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部